The Patient Registry Software Market is expected to grow from USD 10.87 billion in 2019 to USD 25.29 billion by 2026 at a CAGR of 12.82% from 2020 to 2026.
A patient registry is a record that gathers unvarying data about a population of disease or condition, and that supports a predefined clinical or scientific. Patient registry software is a database creation software used to collect secondary data related to diagnosis, procedure, or condition of the patient, for noting the number of new medical devices being used or going through a new procedure. Patient registry databases are used to develop clinical research in the field of rare and chronic diseases for the development of patient care. These databases are important to assess the feasibility of clinical trials and support patient enrollment procedures to evaluate the impact of new interventions. In healthcare organizations like hospitals and nursing homes, patient registry databases collect and store patient information to define particular diseases or medical conditions. The global market is characterized based on many types of database, product, functionality, delivery mode, and end-users. Based on types of databases, the report covers chronic disease, rare disease, cancer, cardiovascular, and diabetes registries. Based on the types of products, the report covers standalone and integrated software. Integrated software represents the fastest increasing segment in the global market. Based on functionality, the report covers the point of care, product outcome evaluation, patient care management, and population health management. Based on delivery mode, the report contains analyses of subscription and ownership models. The subscription model represents the fastest-growing delivery model in the global market. The global market is segregated on the basis of Type of Software as Integrated Software and Stand-alone Software. Based on Type of Registry the global market is segmented in Health Service Registries, Product Registries, and Disease Registries. Based on End User the global market is segmented in Pharmaceutical, Biotechnology, and Medical Device Companies, Government Organizations, and Third Party Administrators, Hospitals, and Other End Users.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Altavoice, Healthdiary Inc, Phamax AG, Lumedx, Arbormetrix, Inc, Phytel, Inc, Imagetrend, Inc, Figmd, Inc, Liaison Technologies, Cecity.Com, Inc, and others are among the major players in the market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Patient Registry Software market has been segmented as below:
By Type of Software
By Type of Registry
By End-User
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share. Major industry players with significant revenue share include Altavoice, Healthdiary Inc, Phamax AG, Lumedx, Arbormetrix, Inc, Phytel, Inc, Imagetrend, Inc, Figmd, Inc, Liaison Technologies, Cecity.Com, Inc, and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Integrated Software
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Stand-alone Software
5.3.1 Market Overview
5.3.2 Market Size and Forecast
6.1 Introduction
6.2 Health Service Registries
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Product Registries
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Disease Registries
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 Pharmaceutical, Biotechnology, and Medical Device Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Government Organizations and Third Party Administrators
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Hospitals
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Other End Users
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8.1 Introduction
8.2 Europe
8.2.1 Europe Market, By Type of Software
8.2.2 Europe Market, By Type of Registry
8.2.3 Europe Market, By End User
8.3 North America
8.3.1 North America Market, By Type of Software
8.3.2 North America Market, By Type of Registry
8.3.3 North America Market, By End User
8.4 Asia Pacific
8.4.1 Asia Pacific Market, By Type of Software
8.4.2 Asia Pacific Market, By Type of Registry
8.4.3 Asia Pacific Market, By End User
8.5 Rest of The World
8.5.1 Rest of The World Market, By Type of Software
8.5.2 Rest of The World Market, By Type of Registry
8.5.3 Rest of The World Market, By End User
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10.1 Altavoice
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Healthdiary Inc
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Phamax AG
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Lumedx
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Arbormetrix, Inc
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Phytel, Inc
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Imagetrend, Inc
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Figmd, Inc
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Liaison Technologies
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Cecity.Com, Inc
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
10.11 Dacima Software, Inc
10.11.1 Company Overview
10.11.2 Product/Service Landscape
10.11.3 Financial Overview
10.11.4 Recent Developments
10.12 Global Vision Technologies, Inc
10.12.1 Company Overview
10.12.2 Product/Service Landscape